Tysabri (natalizumab)

pCPA File Number: 23369
Negotiation Status:
Active Negotiation
Indication(s):
Multiple Sclerosis, Relapsing-Remitting
Sponsor/Manufacturer:
Biogen Canada Inc.
CDA-AMC Project Number:
TS0004-000
pCPA Engagement Letter Issued:
Negotiation Process Concluded:
Not Applicable